Alembic receives USFDA approval for Doxycycline Hyclate, up 8 per cent Alembic receives USFDA approval for Doxycycline Hyclate, up 8 per cent DSIJ Intelligence / Thursday, June 14, 2018 0 1521 Article rating: 5.0 Pharma major Alembic Pharmaceuticals bagged the approval of US Food and Drugs Association for its abbreviated new drug application (ANDA) for Doxycycline Hyclate capsules. Read more
ICICI Bank to sell stake in ICICI Pru ICICI Bank to sell stake in ICICI Pru DSIJ Intelligence / Thursday, June 14, 2018 0 1504 Article rating: 5.0 ICICI Bank received approval from its board of directors for sale of 2 per cent stake in ICICI Prudential through an offer for sale. Read more
Five stocks with selling interest Five stocks with selling interest Shital Jibhe / Thursday, June 14, 2018 0 1379 Article rating: 5.0 Overall volumes in futures & options currently stand at 73.61 lakh contracts with a turnover of Rs. 6,93,000.92 crore. Read more
Five stocks with buying interest Five stocks with buying interest Shital Jibhe / Thursday, June 14, 2018 0 1766 Article rating: 5.0 Overall volumes in futures & options currently stand at 73.61 lakh contracts with a turnover of Rs. 6,93,000.92 crore. Read more
Lupin launches Tobramycin Inhalation Solution USP in the US Lupin launches Tobramycin Inhalation Solution USP in the US DSIJ Intelligence / Wednesday, June 13, 2018 0 1586 Article rating: 4.7 In a significant development, Lupin launched its generic Tobramycin Inhalation Solution USP in the US markets on Wednesday. Read more